C07J 5/0061
Substituted in position 16
Official title: {substituted in position 16}
C07J5/0061 (Substituted in position 16) appears on 147 US grants and 47 published applications in this corpus.
Search patents in C07J- Granted patents
- 147
- Published applications
- 47
- Assignees
- 63
- Inventors
- 265
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 7 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 11 | 0 |
| 1981 | 7 | 0 |
| 1982 | 7 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 8 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 10 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 9 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 2 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 3 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 1 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 3 | 2 |
| 2018 | 2 | 2 |
| 2019 | 2 | 3 |
| 2020 | 3 | 0 |
| 2021 | 0 | 3 |
| 2022 | 1 | 4 |
| 2023 | 2 | 4 |
| 2024 | 0 | 4 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Crystalline forms of dexamethasone dimers and uses thereof18 Nov 2025US 12,473,326 B2Ripple Therapeutics Corporation
- Non-hormonal steroid modulators of NF-kB for treatment of disease5 Dec 2023US 11,833,159 B2ReveraGen BioPharma, Inc.
- Method for preparing 16Alpha-hydroxyprednisolone4 Apr 2023US 11,618,766 B2Zhejiang Shenzhou Pharmaceutical Company Limited
- Heterodimer compositions and methods for the treatment of ocular disorders22 Mar 2022US 11,279,729 B2Ripple Therapeutics Corporation
- Non-hormonal steroid modulators of NF-kB for treatment of disease8 Dec 2020US 10,857,161 B2ReveraGen BioPharma, Inc.
- Non-hormonal steroid modulators of nf-kb for treatment of disease3 Sep 2026US 2026/0256810 A1ReveraGen BioPharma, Inc.
- Diastereomeric conjugate compositions and methods of making and using same1 Jan 2026US 2026/0001905 A1Osteoanalgesia, LLC
- Processable compositions and use for the same20 Feb 2025US 2025/0057962 A1Ripple Therapeutics Corporation
- Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate14 Nov 2024US 2024/0374734 A1Integrated Nanotherapeutics Inc.
- Stable isoquinoline-corticosteroid conjugates and uses thereof17 Oct 2024US 2024/0343755 A1Alcon Inc.
Most cited
By later US patents
- Micronised beclomethasone dipropionate monohydrate compositions and methods of use111US 4,866,051 AGlaxo Group Limited · 1989
- Liposomes containing steroid esters102US 4,693,999 AAktiebolaget Draco · 1987
- Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions72US 5,482,934 AEspecialidades Latinas Medicamentos Universales, S.A. (Elmu, S.A.) · 1996
- Process for the preparation of 17.alpha.-hydroxyprogesterones and corticoids from androstenes48US 4,041,055 AThe Upjohn Company · 1977
- Topical clindamycin preparations46US 4,018,918 AThe Upjohn Company · 1977